Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;72(3):381-93.
doi: 10.1111/j.1365-2125.2011.03991.x.

Neurotoxic effects associated with antibiotic use: management considerations

Affiliations
Review

Neurotoxic effects associated with antibiotic use: management considerations

Marie F Grill et al. Br J Clin Pharmacol. 2011 Sep.

Abstract

The clinical manifestations of antibiotic-induced neurotoxic effects, the underlying mechanisms and management strategies have been reviewed. PubMed and OVID searches (January 1960-June 2010) were conducted using search terms such as antibiotics, side effects, neurotoxicity and encephalopathy which yielded approximately 300 articles. All relevant case reports, case series, letters and retrospective reviews describing neurotoxic effects and those discussing mechanisms of neurotoxicity were included. Antibiotic-induced neurotoxic side effects can have a myriad of neurologic presentations. Patients with prior central nervous system (CNS) disease, renal insufficiency and advanced age may be particularly vulnerable. Treatment consists of discontinuation of the offending agent, use of antiepileptic drugs in the case of seizures or status epilepticus and haemodialysis in certain cases. The risk of CNS toxicity may be reduced via dosage adjustments in high risk populations. Awareness of the potential neurotoxic clinical manifestations of various antibiotics and high degree of vigilance in critically ill patients is essential in identifying a potentially serious, though reversible complications of antibiotic therapy particularly with the advent of newer antimicrobial agents.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Management algorithm for antibiotic neurotoxicity: high risk patients

References

    1. Snavely S, Hodges G. The neurotoxicity of antibacterial agents. Ann Intern Med. 1984;101:92–104. - PubMed
    1. Chow KM, Hui KC, Szetp CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis. 2005;24:649–53. - PubMed
    1. Chow K, Szeto CC, Hui AC, Li PK. Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrobial Agents. 2004;23:213–7. - PubMed
    1. Bischoff A, Meier C, Roth F. Gentamicin neurotoxicity (polyneuropathy – encephalopathy) Schweiz Med Wochenschr. 1977;107:3–8. - PubMed
    1. Watanabe I, Hodges GR, Dworzack DL, Kepes JJ, Duensing GF. Neurotoxicity of intrathecal gentamicin: a case report and experimental study. Ann Neurol. 1978;4:564–72. - PubMed

MeSH terms

Substances